NCT05971758 2025-07-04
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
University of California, Los Angeles
Phase 2 Recruiting
University of California, Los Angeles
Jonsson Comprehensive Cancer Center